Covered recipient · General Payments record
MICHELLE MCCANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,077.59
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,259.63 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $148.91 | 1 |
| Janssen Pharmaceuticals, Inc | $136.56 | 1 |
| Celltrion USA Inc. | $134.72 | 1 |
| Mylan Specialty L.P. | $124.99 | 1 |
| Phathom Pharmaceuticals, Inc. | $124.99 | 1 |
| Grifols USA, LLC | $120.18 | 1 |
| Gilead Sciences, Inc. | $119.99 | 1 |
| Vanda Pharmaceuticals Inc. | $119.31 | 1 |
| Neurelis, Inc. | $117.44 | 1 |
| CSL Behring | $112.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $148.91 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142292395 | CMS |
| Celltrion USA Inc. | $134.72 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075864951 | CMS |
| CSL Behring | $112.54 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134630043 | CMS |
| Gilead Sciences, Inc. | $119.99 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133669106 | CMS |
| Grifols USA, LLC | $120.18 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124718078 | CMS |
| Janssen Pharmaceuticals, Inc | $136.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078123404 | CMS |
| Mylan Specialty L.P. | $124.99 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147285088 | CMS |
| Neurelis, Inc. | $117.44 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145667201 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.99 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151187238 | CMS |
| Vanda Pharmaceuticals Inc. | $119.31 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133956864 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.